Understanding Market Value of Securities and ETFs

By: Montana Timpson

Are recent tech and biotech security and ETF runups cause for bullish celebrations or bearish concerns for a potential near-term catalyst for correction?

One biotech company leading in the news is vaccine developer Moderna Inc. (MNRA), whose stock pared back 10% in a recent afternoon trading session after surging 55% in the three trading days prior. Even after setting another intraday record for the fourth straight session, Moderna’s 10% nose-dive supported bearish market expectations, while bulls expect higher pricing to prevail after the pandemic winds down. To understand both bearish and bullish perspectives in this period of market volatility, traders must understand the defining valuations of securities.

Overvalued Securities
A stock that is “overvalued” has a current price that is not justified by its earnings outlook, or the P/E ratio, which analyzes a company’s stock price relative to its earnings. An overvalued stock traditionally trades at a rate significantly in excess of its peers, which can occur for a litany of reasons.

While growth stocks are often big winners during a bull market, they tend to endure tough sell-offs during market corrections due to their overvaluation.

Fully Valued Securities
In contrast to an overvalued stock, a fully valued stock is a security whose price reflects a full and fair value, according to market analysts. In theory, a stock priced at fair market value is unlikely to suffer any short-term price changes. If a stock deemed “fully valued” were to increase suddenly in price, it would be considered overvalued. In tandem, if it were to decrease suddenly, it would be considered undervalued.

Undervalued Securities
If a stock is considered “undervalued,” the security is trading at a price presumed by analysts to be less than the security’s true intrinsic value. An undervalued stock can be assessed by considering company fundamentals, including financial statements, cash flow, profit generation, return on assets and capital management.

Undervalued securities often come into play in “value investing” trading strategies, in which traders aim to profit by buying valuable stocks at a discounted price.

For more articles and professional trading resources, sign up for our newsletter today.

Active Trading with Lightspeed
Lightspeed provides professional traders with all the tools required to help them find success in stock trading, and we have been developing and honing our active trader platform to offer an optimal user experience. With the intuitive interface layouts and institutional quality stock and options scanners, we aim to help traders reach their goals, no matter what their strategy is. We also offer our clients some of the lowest trading fees in the industry.

For more information on a professional trading platform with Lightspeed, please call us at 1-888-577-3123, request a demo, or to open an account.

Data, information, and material (“content”) are provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities or contracts. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance.

You may also be interested in...

The IPOX® Week, September 20th, 2021
Read More
Understanding the Basics of Option Pricing
Read More
4 Tips for Maximizing Trading Returns
Read More
The IPOX® Week, September 13th, 2021
Read More

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.

OK